Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, said it will further enhance and develop the existing collaboration in Japan with Summit Pharmaceuticals International Corporation (SPI), a wholly owned subsidiary of Sumitomo Corporation. Through the collaboration with SPI, Rentschler Biopharma has secured new contracts with Japanese pharmaceutical companies. SPI and Rentschler Biopharma are working together with Japanese clients to out...